Doxorubicin-induced heart failure in cancer patients: A cohort study based on the Korean National Health Insurance Database.
Young Ae KimHyunsoon ChoNayoung LeeSo-Youn JungSung Hoon SimIn Hae ParkSunmi LeeEun-Sook LeeHak Jin KimPublished in: Cancer medicine (2018)
In cancer patients treated with doxorubicin, management of risk factors, early detection, and treatment for doxorubicin-induced HF might be critical for patient survival.
Keyphrases
- health insurance
- heart failure
- drug delivery
- risk factors
- high glucose
- diabetic rats
- cancer therapy
- drug induced
- affordable care act
- papillary thyroid
- quality improvement
- squamous cell carcinoma
- endothelial cells
- atrial fibrillation
- oxidative stress
- acute heart failure
- squamous cell
- free survival
- replacement therapy
- childhood cancer